| Authors: |
Courneya KS; University of Alberta, Edmonton, Alberta, Canada. kerry.courneya@ualberta.ca., Vardy JL; University of Sydney, Sydney, New South Wales, Australia., O'Callaghan CJ; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Friedenreich CM; Alberta Health Services, Calgary, Alberta, Canada., Campbell KL; University of British Columbia, Vancouver, British Columbia, Canada., Prapavessis H; Western University, London, Ontario, Canada., Crawford JJ; University of Alberta, Edmonton, Alberta, Canada., O'Brien P; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Dhillon HM; University of Sydney, Sydney, New South Wales, Australia., Jonker DJ; The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Chua NS; Cross Cancer Institute, Edmonton, Alberta, Canada., Lupichuk S; Tom Baker Cancer Center, Calgary, Alberta, Canada., Sanatani MS; London Regional Cancer Center, London, Ontario, Canada., Gill S; British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Meyer RM; Juravinski Hospital and Cancer Centre and McMaster University, Hamilton, Ontario, Canada., Begbie S; North Coast Cancer Institute, Coffs Harbour, New South Wales, Australia., Bonaventura T; Newcastle Private Hospital, New South Wales, Australia., Burge ME; Royal Brisbane & Women's Hospital, Herston, Queensland, Australia., Turner J; University of Sydney, Sydney, New South Wales, Australia., Tu D; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Booth CM; Queen's University, Kingston, Ontario, Canada. |
